Nicolas Morin

2.1k total citations
38 papers, 1.5k citations indexed

About

Nicolas Morin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Nicolas Morin has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 14 papers in Neurology. Recurrent topics in Nicolas Morin's work include Neuroscience and Neuropharmacology Research (12 papers), Neurological disorders and treatments (11 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Nicolas Morin is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neurological disorders and treatments (11 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Nicolas Morin collaborates with scholars based in Canada, France and Switzerland. Nicolas Morin's co-authors include Thérèse Di Paolo, Laurent Grégoire, F. Gasparini, Baltazar Gomez‐Mancilla, Jean François, Marina Coquery, Cécile Miège, Jérôme Randon, Marc Morissette and Ceren Alkım and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Diabetes.

In The Last Decade

Nicolas Morin

36 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Morin Canada 22 581 431 372 214 128 38 1.5k
Jian‐Hong Zhu China 24 1.1k 1.9× 237 0.5× 347 0.9× 160 0.7× 61 0.5× 99 2.7k
Pratibha Tripathi India 23 946 1.6× 519 1.2× 220 0.6× 48 0.2× 205 1.6× 43 2.4k
Lidia Strużyńska Poland 26 350 0.6× 383 0.9× 73 0.2× 181 0.8× 75 0.6× 76 2.0k
Evelyn Tiffany‐Castiglioni United States 32 810 1.4× 547 1.3× 236 0.6× 51 0.2× 158 1.2× 85 2.9k
Zongyong Zhang China 24 407 0.7× 176 0.4× 312 0.8× 70 0.3× 87 0.7× 53 1.4k
Shu Yang Australia 22 813 1.4× 141 0.3× 708 1.9× 52 0.2× 64 0.5× 48 1.7k
Yoko Kitagawa Japan 20 399 0.7× 111 0.3× 132 0.4× 52 0.2× 178 1.4× 59 2.0k
Serena Silvestro Italy 25 513 0.9× 178 0.4× 105 0.3× 53 0.2× 258 2.0× 46 1.8k
Zhengping Yu China 29 838 1.4× 246 0.6× 61 0.2× 144 0.7× 110 0.9× 95 2.5k
Devendra Parmar India 28 1.1k 1.9× 148 0.3× 121 0.3× 167 0.8× 283 2.2× 92 3.0k

Countries citing papers authored by Nicolas Morin

Since Specialization
Citations

This map shows the geographic impact of Nicolas Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Morin more than expected).

Fields of papers citing papers by Nicolas Morin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Morin. The network helps show where Nicolas Morin may publish in the future.

Co-authorship network of co-authors of Nicolas Morin

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Morin. A scholar is included among the top collaborators of Nicolas Morin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Morin. Nicolas Morin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morin, Nicolas, Sylvine Carrondo Cottin, Stéphan Saïkali, Karine Michaud, & Myreille D’Astous. (2023). NCMP-12. PREVALENCE OF RADIONECROSIS IN RECURRENT GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v209–v209.
2.
François, Jean, Ceren Alkım, & Nicolas Morin. (2020). Engineering microbial pathways for production of bio-based chemicals from lignocellulosic sugars: current status and perspectives. Biotechnology for Biofuels. 13(1). 118–118. 76 indexed citations
3.
Morin, Nicolas, et al.. (2020). Transforming Candida hispaniensis, a promising oleaginous and flavogenic yeast. Yeast. 37(5-6). 348–355. 10 indexed citations
4.
Morissette, Marc, Nicolas Morin, Laurent Grégoire, et al.. (2016). Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. Biochemical Pharmacology. 109. 62–69. 10 indexed citations
5.
Morin, Nicolas, Marc Morissette, Laurent Grégoire, & Thérèse Di Paolo. (2016). mGlu5, Dopamine D2and Adenosine A2AReceptors in L-DOPA-induced Dyskinesias. Current Neuropharmacology. 14(5). 481–493. 17 indexed citations
6.
Devillers, Hugo, Nicolas Morin, & Cécile Neuvéglise. (2015). Enhancing Structural Annotation of Yeast Genomes with RNA-Seq Data. Methods in molecular biology. 1361. 41–56. 1 indexed citations
7.
Morin, Nicolas, Marc Morissette, Laurent Grégoire, et al.. (2015). Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. Neuropharmacology. 99. 356–368. 15 indexed citations
8.
Morin, Nicolas, et al.. (2014). Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys. Experimental Neurology. 261. 816–825. 2 indexed citations
9.
Morin, Nicolas & Thérèse Di Paolo. (2014). Interaction of Adenosine Receptors with Other Receptors from Therapeutic Perspective in Parkinson's Disease. International review of neurobiology. 119. 151–167. 13 indexed citations
10.
Morin, Nicolas, Marc Morissette, Laurent Grégoire, & Thérèse Di Paolo. (2014). Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 56. 27–38. 8 indexed citations
11.
12.
Morin, Nicolas, et al.. (2013). Modeling dyskinesia in animal models of Parkinson disease. Experimental Neurology. 256. 105–116. 73 indexed citations
13.
Morin, Nicolas, Marc Morissette, Laurent Grégoire, et al.. (2013). Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in l-DOPA-treated parkinsonian monkeys. Neuropharmacology. 73. 216–231. 50 indexed citations
14.
Grégoire, Laurent, Nicolas Morin, Bazoumana Ouattara, et al.. (2011). The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in l-Dopa-treated parkinsonian monkeys. Parkinsonism & Related Disorders. 17(4). 270–276. 89 indexed citations
15.
Morin, Nicolas, Julien Cescut, Athanasios Béopoulos, et al.. (2011). Transcriptomic Analyses during the Transition from Biomass Production to Lipid Accumulation in the Oleaginous Yeast Yarrowia lipolytica. PLoS ONE. 6(11). e27966–e27966. 112 indexed citations
16.
Robichaud, Joël, Jean‐François Fournier, Sébastien Gagné, et al.. (2010). Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14. Bioorganic & Medicinal Chemistry Letters. 21(14). 4366–4368. 44 indexed citations
17.
Morin, Nicolas, Laurent Grégoire, Baltazar Gomez‐Mancilla, F. Gasparini, & Thérèse Di Paolo. (2010). Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. Neuropharmacology. 58(7). 981–986. 99 indexed citations
18.
Morin, Nicolas, Tatiana Vallaeys, Larissa Hendrickx, Natalie Leys, & Annick Wilmotte. (2009). An efficient DNA isolation protocol for filamentous cyanobacteria of the genus Arthrospira. Journal of Microbiological Methods. 80(2). 148–154. 62 indexed citations
19.
Funicello, Marcella, Michela Novelli, Maurizio Ragni, et al.. (2007). Cathepsin K Null Mice Show Reduced Adiposity during the Rapid Accumulation of Fat Stores. PLoS ONE. 2(8). e683–e683. 45 indexed citations
20.
Wang, Wuyi, et al.. (2000). Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules. Bioorganic & Medicinal Chemistry Letters. 10(11). 1151–1154. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian‐Hong Zhu Breakdown of academic impact, for papers by Pratibha Tripathi Breakdown of academic impact, for papers by Lidia Strużyńska Breakdown of academic impact, for papers by Evelyn Tiffany‐Castiglioni Breakdown of academic impact, for papers by Zongyong Zhang Breakdown of academic impact, for papers by Shu Yang Breakdown of academic impact, for papers by Yoko Kitagawa Breakdown of academic impact, for papers by Serena Silvestro Breakdown of academic impact, for papers by Zhengping Yu Breakdown of academic impact, for papers by Devendra Parmar
Rankless by CCL
2026